Does Red Light Therapy Help Myopia in Children?
Repeated low-level red light therapy has shown a genuine ability to slow myopia progression in children in randomized trials, which makes it one of the more promising uses of light for the eye. But it comes with a serious asterisk that responsible coverage cannot skip: there are unresolved questions about retinal safety, including case reports of possible harm. We grade it Promising, but safety-flagged, and we are clear that this is a decision for a pediatric eye specialist, not a consumer purchase. This review gives the honest picture, including the simpler habit that protects children’s eyes.
It is an evidence summary, not medical advice. We sell no hardware and grade the evidence as we find it.
Quick verdict
We grade repeated low-level red light (RLRL) for childhood myopia Promising but safety-flagged. Randomized trials report it meaningfully slows the progression of nearsightedness in children, which is real evidence of effect. The flag is that its long-term retinal safety is not settled, with case reports raising concern, so it should only be considered under the supervision of a pediatric ophthalmologist, never as a do-it-yourself device.
What is childhood myopia?
Myopia, or nearsightedness, is when the eye grows too long and distant objects look blurry. It usually begins and progresses during childhood, and its prevalence has risen sharply worldwide. The concern is not just glasses: higher myopia in adulthood raises the lifetime risk of serious problems like retinal detachment and myopic maculopathy, so slowing progression in childhood has real long-term value.
That is why myopia control, a set of interventions aimed at slowing how fast a child’s myopia worsens, has become an active field, and repeated low-level red light is one of the newer entrants.
What the evidence shows
The evidence for RLRL is more substantial than for most light-therapy uses. A multicenter randomized controlled trial found that repeated low-level red-light therapy slowed myopia progression and reduced the eye’s axial elongation in children compared with standard single-vision glasses (multicenter RLRL trial, 2022). Several trials have now pointed in the same direction, which is a stronger signal than a single study.
So the effect appears real. What is not yet settled is the long-term safety of repeatedly delivering red laser light to children’s retinas, and that is the crux of the caution below.
The safety flag
This is the part that sets myopia apart from the rest of this field. RLRL devices deliver red light directly toward the retina, and there have been case reports of possible retinal damage associated with their use, prompting caution from clinicians even as the efficacy data accumulate. The long-term safety profile in growing eyes is simply not established yet.
This does not erase the evidence of benefit, but it changes how the benefit should be weighed. A treatment that works but whose safety is uncertain is one to use only under close professional supervision, with proper retinal monitoring, and after a careful conversation about risks and benefits. It is emphatically not something to buy and run at home unsupervised. The broader ocular-PBM literature treats retinal dose and safety as the central variable for exactly this reason (Gaspari et al., 2024).
What else protects children’s eyes
Alongside any clinical myopia-control decision, one habit has strong, safe evidence: time outdoors. A randomized trial found that adding 40 minutes of outdoor activity at school cut the three-year incidence of myopia in young children from 39.5% to 30.4% (He et al., JAMA 2015). It is free, carries no risk, and benefits children’s health more broadly.
Other established myopia-control options, such as low-dose atropine eye drops and specialized contact lenses, also have evidence and a longer track record than RLRL. A pediatric eye specialist can weigh these against red light for a given child. For the related question of whether screen eyewear helps, see our blue light glasses for kids guide.
Frequently asked questions
Does red light therapy slow myopia in children?
The evidence suggests it does. A multicenter randomized trial found repeated low-level red light slowed myopia progression and axial elongation in children (multicenter RLRL trial, 2022), with several trials pointing the same way. We grade it promising, but safety-flagged.
Is red light therapy safe for children’s eyes?
That is the open question. The therapy delivers red light toward the retina, and there are case reports of possible retinal harm, so long-term safety in children is not settled. It should only be used under a pediatric ophthalmologist’s supervision with retinal monitoring.
Can I buy a red light device to treat my child’s myopia at home?
This is not something to self-administer. Given the unresolved safety questions, RLRL for myopia is a clinical decision requiring professional supervision and monitoring, not a consumer purchase.
What else slows myopia in children?
Time outdoors has strong, safe evidence, with a trial showing 40 minutes of outdoor activity reduced myopia incidence (He et al., JAMA 2015). Low-dose atropine drops and specialized contact lenses are other evidence-based options to discuss with a specialist.
Is this the same as blue light glasses for kids?
No. Blue light glasses filter screen light and are not proven to help children’s eyes, while RLRL is an active myopia-control treatment with efficacy evidence and safety questions. See our blue light glasses for kids guide for that separate topic.
The bottom line
Repeated low-level red light is a genuinely Promising myopia-control treatment, with randomized trials showing it slows progression in children, but the unresolved retinal-safety questions mean it must be handled as a supervised clinical decision, not a home device. Pair any decision with the safe, well-evidenced habit of time outdoors, and weigh red light against atropine and specialized lenses with a pediatric eye specialist. For the separate screen-eyewear question, see our blue light glasses for kids guide.
This review is an educational summary of published evidence. It is not medical advice and does not create a doctor-patient relationship. Decisions about a child’s eyes should always be made with a qualified pediatric eye-care professional.


